Association between surrogate indices of fatty liver and the risk of colorectal cancer: a cross-sectional United States study.

IF 1.7 4区 医学 Q4 ONCOLOGY Translational cancer research Pub Date : 2025-01-31 Epub Date: 2025-01-23 DOI:10.21037/tcr-24-1444
Chenyuan Shi, Chao Yuan, Yifei Hao, Zheng Zhou, Yigang Zhang
{"title":"Association between surrogate indices of fatty liver and the risk of colorectal cancer: a cross-sectional United States study.","authors":"Chenyuan Shi, Chao Yuan, Yifei Hao, Zheng Zhou, Yigang Zhang","doi":"10.21037/tcr-24-1444","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The presence of fatty liver (FL) has been suggested to influence the incidence of colorectal cancer (CRC). This study aimed to evaluate the predictive utility of six alternative indices of FL-namely, liver fat percentage (PLF), lipid accumulation product (LAP), hepatic steatosis index (HSI), United States fatty liver index (USFLI), fatty liver index (FLI), and Zhejiang University index (ZJU)-in assessing the risk of CRC. We aimed to determine their effectiveness in predicting CRC risk by comparing these surrogate indices.</p><p><strong>Methods: </strong>Data for this study were derived from the National Health and Nutrition Examination Survey (NHANES) conducted between 2003 and 2018, focusing on adults over 20 years old. The six FLIs were calculated using established methodologies outlined in prior research. To identify key variables, the Boruta algorithm was employed. The relationships between FLIs and CRC risk were assessed using multivariable logistic regression, generalized linear models (GLMs), and restricted cubic spline (RCS) models. Additionally, subgroup analyses were performed to investigate the effects of potential confounders.</p><p><strong>Results: </strong>Among the 16,250 individuals surveyed, 96 were diagnosed with CRC. Those with CRC exhibited significantly higher levels of PLF (4.65 <i>vs.</i> 3.31, P=0.004), LAP (55.63 <i>vs.</i> 42.34, P=0.04), USFLI (23.22 <i>vs.</i> 17.83, P<0.001), and FLI (58.16 <i>vs.</i> 50.86, P=0.048) compared to individuals without CRC. Multivariate logistic regression and RCS analyses indicated that, of the six indices, only USFLI was significantly associated with an increased risk of CRC. Notably, further stratification of USFLI revealed that this association was consistently stronger in individuals aged over 65 years [odds ratio (OR) =1.023; 95% confidence interval (CI): 1.005-1.041; P=0.01] and among non-smokers (OR =1.018; 95% CI: 1.003-1.033; P=0.02) after adjusting for multiple confounders.</p><p><strong>Conclusions: </strong>The USFLI index demonstrated a more significant association with the risk of CRC compared to the other five alternative FLIs, highlighting its potential utility in predicting CRC risk in clinical settings.</p>","PeriodicalId":23216,"journal":{"name":"Translational cancer research","volume":"14 1","pages":"313-326"},"PeriodicalIF":1.7000,"publicationDate":"2025-01-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11833385/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Translational cancer research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.21037/tcr-24-1444","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/23 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: The presence of fatty liver (FL) has been suggested to influence the incidence of colorectal cancer (CRC). This study aimed to evaluate the predictive utility of six alternative indices of FL-namely, liver fat percentage (PLF), lipid accumulation product (LAP), hepatic steatosis index (HSI), United States fatty liver index (USFLI), fatty liver index (FLI), and Zhejiang University index (ZJU)-in assessing the risk of CRC. We aimed to determine their effectiveness in predicting CRC risk by comparing these surrogate indices.

Methods: Data for this study were derived from the National Health and Nutrition Examination Survey (NHANES) conducted between 2003 and 2018, focusing on adults over 20 years old. The six FLIs were calculated using established methodologies outlined in prior research. To identify key variables, the Boruta algorithm was employed. The relationships between FLIs and CRC risk were assessed using multivariable logistic regression, generalized linear models (GLMs), and restricted cubic spline (RCS) models. Additionally, subgroup analyses were performed to investigate the effects of potential confounders.

Results: Among the 16,250 individuals surveyed, 96 were diagnosed with CRC. Those with CRC exhibited significantly higher levels of PLF (4.65 vs. 3.31, P=0.004), LAP (55.63 vs. 42.34, P=0.04), USFLI (23.22 vs. 17.83, P<0.001), and FLI (58.16 vs. 50.86, P=0.048) compared to individuals without CRC. Multivariate logistic regression and RCS analyses indicated that, of the six indices, only USFLI was significantly associated with an increased risk of CRC. Notably, further stratification of USFLI revealed that this association was consistently stronger in individuals aged over 65 years [odds ratio (OR) =1.023; 95% confidence interval (CI): 1.005-1.041; P=0.01] and among non-smokers (OR =1.018; 95% CI: 1.003-1.033; P=0.02) after adjusting for multiple confounders.

Conclusions: The USFLI index demonstrated a more significant association with the risk of CRC compared to the other five alternative FLIs, highlighting its potential utility in predicting CRC risk in clinical settings.

Abstract Image

Abstract Image

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
脂肪肝替代指标与结直肠癌风险之间的关联:一项美国横断面研究。
背景:脂肪肝(FL)的存在已被认为影响结直肠癌(CRC)的发病率。本研究旨在评估肝脂率(PLF)、脂质积累积(LAP)、肝脂肪变性指数(HSI)、美国脂肪肝指数(USFLI)、脂肪肝指数(FLI)和浙江大学指数(ZJU)在评估结直肠癌风险中的预测效用。我们的目的是通过比较这些替代指标来确定它们预测结直肠癌风险的有效性。方法:本研究的数据来自2003年至2018年进行的国家健康与营养检查调查(NHANES),重点关注20岁以上的成年人。六个fli是使用先前研究中概述的既定方法计算的。为了识别关键变量,采用Boruta算法。使用多变量logistic回归、广义线性模型(GLMs)和限制三次样条(RCS)模型评估FLIs与CRC风险之间的关系。此外,进行亚组分析以调查潜在混杂因素的影响。结果:在接受调查的16250人中,96人被诊断为结直肠癌。结直肠癌患者的PLF (4.65 vs. 3.31, P=0.004)、LAP (55.63 vs. 42.34, P=0.04)、USFLI (23.22 vs. 17.83, P= 50.86, P=0.048)水平明显高于无结直肠癌患者。多因素logistic回归和RCS分析表明,在6个指标中,只有USFLI与CRC风险增加显著相关。值得注意的是,进一步的USFLI分层显示,这种关联在65岁以上的个体中始终更强[优势比(OR) =1.023;95%置信区间(CI): 1.005-1.041;P=0.01]和非吸烟者(OR =1.018;95% ci: 1.003-1.033;P=0.02)。结论:与其他5种可选fli相比,USFLI指数与结直肠癌风险的相关性更显著,突出了其在临床环境中预测结直肠癌风险的潜在效用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
2.10
自引率
0.00%
发文量
252
期刊介绍: Translational Cancer Research (Transl Cancer Res TCR; Print ISSN: 2218-676X; Online ISSN 2219-6803; http://tcr.amegroups.com/) is an Open Access, peer-reviewed journal, indexed in Science Citation Index Expanded (SCIE). TCR publishes laboratory studies of novel therapeutic interventions as well as clinical trials which evaluate new treatment paradigms for cancer; results of novel research investigations which bridge the laboratory and clinical settings including risk assessment, cellular and molecular characterization, prevention, detection, diagnosis and treatment of human cancers with the overall goal of improving the clinical care of cancer patients. The focus of TCR is original, peer-reviewed, science-based research that successfully advances clinical medicine toward the goal of improving patients'' quality of life. The editors and an international advisory group of scientists and clinician-scientists as well as other experts will hold TCR articles to the high-quality standards. We accept Original Articles as well as Review Articles, Editorials and Brief Articles.
期刊最新文献
Identification of immune-related targets of N6-methyladenosine regulators in hepatocellular carcinoma via RNA-seq analysis. A case report of idiopathic pulmonary fibrosis concurrent with EGFR 19 deletion lung adenocarcinoma. A novel gene signature based on Like-Smith family members-related genes for predicting the prognosis of hepatocellular carcinoma. Improving stratification in HPV-negative head and neck squamous cell carcinoma (HNSCC) using emerging immune-based biomarkers. A multimodal fusion model for bone tumor benign and malignant diagnosis: development and validation with clinical text and radiographs.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1